Discuss pharmacovigilance and Adverse Drug Experience (ADE) Reporting. Explore FDA’s drug safety review activities. Review Medicare, Medicaid, and reimbursement issues. Learn about the Drug Supply Chain Security Act (DSCSA) product tracing requirements.
Michelle R. Ryder, Principal Consultant, Lachman Consultant Services, Inc.
This session was recorded as part of FDLI’s Virtual Introduction to Drug Law and Regulation Course in April 2021.